Internalization of targeted quantum dots by brain capillary endothelial cells in vivo

Journal of Cerebral Blood Flow and Metabolism

Volumn 36, Issue 4, 2015, Pages 731-742

  Paris Robidas, Sarah ^a,b   Brouard, Danny ^c   Emond, Vincent ^a,b   Parent, Martin ^a,d   Calon, Frédéric ^a,b  

^a UNIVERSITÉ LAVAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c Research and Development   (Canada)

^d CENTRE DE RECHERCHE DE L INSTITUT UNIVERSITAIRE EN SANTÉ MENTALE DE QUÉBEC   (Canada)

Author keywords

Blood brain barrier; brain capillary endothelial cells; drug targeting; monoclonal antibody; quantum dot nanocrystals

Indexed keywords

IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY RI7; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; QUANTUM DOT; TRANSFERRIN RECEPTOR; UNCLASSIFIED DRUG; NANOPARTICLE; TFRC PROTEIN, MOUSE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN BLOOD VESSEL; BRAIN CAPILLARY ENDOTHELIAL CELL; CONTROLLED STUDY; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; ENDOCYTOSIS; IMMUNOFLUORESCENCE; IN VITRO STUDY; IN VIVO STUDY; INTERNALIZATION; MALE; MOUSE; MULTIVESICULAR BODY; NONHUMAN; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY; VOLUME OF DISTRIBUTION; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; BLOOD BRAIN BARRIER; BRAIN CIRCULATION; CAPILLARY; CELL LINE; CYTOLOGY; ENDOTHELIUM CELL; GENETICS; METABOLISM; RAT; TISSUE DISTRIBUTION; ULTRASTRUCTURE; VASCULAR ENDOTHELIUM;

ANIMALS; BLOOD-BRAIN BARRIER; CAPILLARIES; CELL LINE; CEREBROVASCULAR CIRCULATION; ENDOCYTOSIS; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; IMMUNOGLOBULIN G; MALE; MICE; MICE, INBRED BALB C; NANOPARTICLES; QUANTUM DOTS; RATS; RECEPTORS, TRANSFERRIN; TISSUE DISTRIBUTION;

EID: 84962425233     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1177/0271678X15608201     Document Type: Article

References (40)

1. Watts RJ and Dennis MS. Bispecific antibodies for delivery into the brain. Curr Opin Chem Biol 2013; 17: 393-399.
2. Neuwelt E, Abbott NJ, Abrey L, et al. Strategies to advance translational research into brain barriers. Lancet Neurol 2008; 7: 84-96.
3. Oldendorf WH. The blood-brain barrier. Exp Eye Res 1977; 25: 177-190.
4. Broadwell RD. Transcytosis of macromolecules through the blood-brain barrier: a cell biological perspective and critical appraisal. Acta Neuropathol 1989; 79: 117-128.
5. Cornford EM and Cornford ME. New systems for delivery of drugs to the brain in neurological disease. Lancet Neurol 2002; 1: 306-315.
6. Ulbrich K, Hekmatara T, Herbert E, et al. Transferrinand transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood-brain barrier (BBB). Eur J Pharm Biopharm 2009; 71: 251-256.
7. Zhang Y, Calon F, Zhu C, et al. Intravenous nonviral gene therapy causes normalization of striatal tyrosine hydroxylase and reversal of motor impairment in experimental parkinsonism. Hum Gene Ther 2003; 14: 1-12.
8. Ulbrich K, Knobloch T and Kreuter J. Targeting the insulin receptor: nanoparticles for drug delivery across the blood-brain barrier (BBB). J Drug Target 2011; 19: 125-132.
9. Demeule M, Currie J-C, Bertrand Y, et al. Involvement of the low-density lipoprotein receptor-related protein in the transcytosis of the brain delivery vector angiopep-2. J Neurochem 2008; 106: 1534-1544.
10. Friden PM, Walus LR, Musso GF, et al. Anti-transferrin receptor antibody and antibody-drug conjugates cross the blood-brain barrier. Proc Natl Acad Sci USA 1991; 88: 4771-4775.
11. Gosk S, Vermehren C, Storm G, et al. Targeting antitransferrin receptor antibody (OX26) and OX26-conjugated liposomes to brain capillary endothelial cells using in situ perfusion. J Cerebral Blood Flow Metab 2004; 24: 1193-1204.
12. Paris-Robidas S, Emond V, Tremblay C, et al. In vivo labeling of brain capillary endothelial cells after intravenous injection of monoclonal antibodies targeting the transferrin receptor. Mol Pharmacol 2011; 80: 32-39.
13. Moos T, Rosengren Nielsen T, Skjørringe T, et al. Iron trafficking inside the brain. J Neurochem 2007; 103: 1730-1740.
14. Roberts RL, Fine RE and Sandra A. Receptor-mediated endocytosis of transferrin at the blood-brain barrier. J Cell Sci 1993; 104: 521-532.
15. Atwal JK, Chen Y, Chiu C, et al. A therapeutic antibody targeting BACE1 inhibits amyloid-b production in vivo. Sci Transl Med 2011; 3: 84ra43.
16. Gabathuler R. Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases. Neurobiol Dis 2010; 37: 48-57.
17. Giepmans BNG, Deerinck TJ, Smarr BL, et al. Correlated light and electron microscopic imaging of multiple endogenous proteins using Quantum dots. Nat Methods 2005; 2: 743-749.
18. Parent M, Wallman M-J and Descarries L. Distribution and ultrastructural features of the serotonin innervation in rat and squirrel monkey subthalamic nucleus. Eur J Neurosci 2010; 31: 1233-1242.
19. Kato S, Itoh K, Yaoi T, et al. Organ distribution of quantum dots after intraperitoneal administration, with special reference to area-specific distribution in the brain. Nanotechnology 2010; 21: 335103.
20. Wang T, Hsieh H, Hsieh Y, et al. The in vivo biodistribution and fate of CdSe quantum dots in the murine model: a laser ablation inductively coupled plasma mass spectrometry study. Anal Bioanal Chem 2012; 404: 3025-3036.
21. Wu D, Clement JG and Pardridge WM. Low blood-brain barrier permeability to azidothymidine (AZT), 3TC, and thymidine in the rat. Brain Res 1998; 791: 313-316.
22. Skarlatos S, Yoshikawa T and Pardridge WM. Transport of [125I]transferrin through the rat blood-brain barrier. Brain Res 1995; 683: 164-171.
23. Wu D, Kang YS, Bickel U, et al. Blood-brain barrier permeability to morphine-6-glucuronide is markedly reduced compared with morphine. Drug Metab Dispos 1997; 25: 768-771.
24. Kalvass JC, Maurer TS and Pollack GM. Use of plasma and brain unbound fractions to assess the extent of brain distribution of 34 drugs: comparison of unbound concentration ratios to in vivo p-glycoprotein efflux ratios. Drug Metab Dispos 2007; 35: 660-666.
25. Moos T and Morgan EH. Restricted transport of antitransferrin receptor antibody (OX26) through the bloodbrain barrier in the rat. J Neurochem 2001; 79: 119-129.
26. Stahl PD and Barbieri MA. Multivesicular bodies and multivesicular endosomes: the 'ins and outs' of endosomal traffic. Sci STKE 2002; 2002: pe32.
27. Aisen P. Transferrin receptor 1. Int J Biochem Cell Biol 2004; 36: 2137-2143.
28. Felber AE, Castagner B, Elsabahy M, et al. siRNA nanocarriers based on methacrylic acid copolymers. J Control Release 2011; 152: 159-167.
29. Harding C, Heuser J and Stahl P. Receptor-mediated endocytosis of transferrin and recycling of the transferrin receptor in rat reticulocytes. J Cell Biol 1983; 97: 329-339.
30. Harding C, Heuser J and Stahl P. Endocytosis and intracellular processing of transferrin and colloidal gold-transferrin in rat reticulocytes: demonstration of a pathway for receptor shedding. Eur J Cell Biol 1984; 35: 256-263.
31. Giometto B, Bozza F, Argentiero V, et al. Transferrin receptors in rat central nervous system. An immunocytochemical study. J Neurol Sci 1990; 98: 81-90.
32. Orita T, Akimura T, Nishizaki T, et al. Transferrin receptors in injured brain. Acta Neuropathol 1990; 79: 686-688.
33. Bickel U, Kang YS, Yoshikawa T, et al. In vivo demonstration of subcellular localization of anti-transferrin receptor monoclonal antibody-colloidal gold conjugate in brain capillary endothelium. J Histochem Cytochem 1994; 42: 1493-1497.
34. Wiley DT, Webster P, Gale A, et al. Transcytosis and brain uptake of transferrin-containing nanoparticles by tuning avidity to transferrin receptor. Proc Natl Acad Sci USA 2013; 110: 8662-8667.
35. Bjorn MJ and Groetsema G. Immunotoxins to the murine transferrin receptor: intracavitary therapy of mice bearing syngeneic peritoneal tumors. Cancer Res 1987; 47: 6639-6645.
36. Yu YJ, Zhang Y, Kenrick M, et al. Boosting brain uptake of a therapeutic antibody by reducing its affinity for a transcytosis target. Sci Transl Med 2011; 3: 84ra44.
37. Pardridge WM. Brain drug development and brain drug targeting. Pharm Res 2007; 24: 1729-1732.
38. Jiang C, Koyabu N, Yonemitsu Y, et al. In vivo delivery of glial cell-derived neurotrophic factor across the bloodbrain barrier by gene transfer into brain capillary endothelial cells. Hum Gene Ther 2003; 14: 1181-1191.
39. Persidsky Y, Ramirez SH, Haorah J, et al. Blood-brain barrier: structural components and function under physiologic and pathologic conditions. J Neuroimmune Pharmacol 2006; 1: 223-236.
40. Kuwahara H, Nishina K, Yoshida K, et al. Efficient in vivo delivery of siRNA into brain capillary endothelial cells along with endogenous lipoprotein. Mol Ther 2011; 19: 2213-2221.